Products for Research Use Only
RegisterLogin

DAPK-IN-2

CAT: 0804-HY-153595-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-153595-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases[1].
CAS Number
304000-05-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
DAPK
Type
Reference compound
Related Pathways
Apoptosis
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/dapk-in-2.html
Purity
98.02
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1OC(C2=CC(OC)=C(OC)C=C2)=N/C1=C\C3=CC=CN=C3
Molecular Formula
C17H14N2O4
Molecular Weight
310.30
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18 (7) :2728-2734.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P1344DAPK Substrate Peptide
HY-15513-01TC-DAPK 6
HY-P1344A-01DAPK Substrate Peptide (TFA)
HY-W011060-01Cryptand 2.2.2
HY-B1500-012,2,2-Trichloroethanol
HY-W0733142,2,2-Trifluoroethoxyamine (hydrochloride)
HY-N2048-012,2':5',2''-Terthiophene
HY-132268-01Cav 2.2 blocker 2
HY-B1500R-012,2,2-Trichloroethanol (Standard)
HY-W011060R-01Cryptand 2.2.2 (Standard)

Alternative Products

CatalogName
BA3401-10DAPK-IN-2
MBS8535003-01DAPK
sc-136286DAPK (17)
QMA69489-01DAPK Inhibitor
E8RT1178DAPK Antibody
561665TC-DAPK 6
TP2205DAPK Substrate Peptide
sc-38976DAPK siRNA (h)
sc-38977-PRDAPK (m) -PR
GTR17963259Dapk-1 Antibody

Popular Products